• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/16/21 9:38:28 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials
    Get the next $LUXA alert in real time by email
    SC 13G 1 eh210130940_13g-lht.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

    Lux Health Tech Acquisition Corp.
    (Name of Issuer)
     
    Class A Common Stock, par value $0.001 per share
    (Title of Class of Securities)
     
    55068A100
    (CUSIP Number)
     
    December 31, 2020
    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ☒ Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☐ Rule 13d-1(d)
     

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

      

     

     

    CUSIP No. 55068A100 SCHEDULE 13G Page 2 of 7

     

     

    1

    NAME OF REPORTING PERSON

     

    D1 Capital Partners L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☐

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    3,000,000

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    3,000,000

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    3,000,000

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.7%

     
    12

    TYPE OF REPORTING PERSON

     

    PN, IA

     

     

     

      

     

     

    CUSIP No. 55068A100 SCHEDULE 13G Page 3 of 7

     

     

    1

    NAME OF REPORTING PERSON

     

    Daniel Sundheim

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☐

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    3,000,000

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    3,000,000

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    3,000,000

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.7%

     
    12

    TYPE OF REPORTING PERSON

     

    IN, HC

     

     

     

      

     

     

    CUSIP No. 55068A100 SCHEDULE 13G Page 4 of 7

     

     

    Item 1(a). Name of Issuer.
       
      Lux Health Tech Acquisition Corp. (the “Issuer”)
       
    Item 1(b). Address of Issuer's Principal Executive Offices.
       
     

    920 Broadway, 11th Floor

    New York, NY 10010

       
    Item 2(a). Name of Person Filing.
       
     

    This statement is filed by D1 Capital Partners L.P. (the “Investment Manager”) and Daniel Sundheim (the “Mr. Sundheim”). The foregoing persons are hereinafter sometimes referred to as the “Reporting Persons.”

     

    The Investment Manager is a registered investment adviser and serves as the investment manager of private investment vehicles and accounts, including D1 Capital Partners Master LP (the “Investment Vehicle”). Mr. Sundheim may be deemed to beneficially own the reported securities by virtue of the fact that Mr. Sundheim indirectly controls the Investment Manager.

     

    The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities reported herein.

       
    Item 2(b). Address of Principal Business Office.
       
     

    D1 Capital Partners L.P.

    9 West 57th Street, 36th Floor

    New York, New York 10019

     

    Daniel Sundheim

    c/o D1 Capital Partners L.P.

    9 West 57th Street, 36th Floor

    New York, New York 10019

       
    Item 2(c). Place of Organization.
       
     

    Investment Manager – Delaware

    Mr. Sundheim – United States of America

       
    Item 2(d). Title of Class of Securities.
       
      Common stock, $0.001 par value (the “Common Stock”)
       
    Item 2(e). CUSIP Number.
       
      55068A100

     

     

      

     

     

    CUSIP No. 55068A100 SCHEDULE 13G Page 5 of 7

     

     

    Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:
           
      (a) ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
      (b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ☒ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
      (f) ☐ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
      (g) ☒ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
      (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
      (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ☐ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
      (k) ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K).
           
     

    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     

    Not applicable.

       
    Item 4. Ownership.
       
      The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentages set forth in this Schedule 13G are calculated based upon an aggregate of 34,500,000 Common Stock outstanding as of December 8, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q for the period ended September 30, 2020.
       
    Item 5. Ownership of Five Percent or Less of a Class.
       
      Not applicable.

     

     

      

     

     

    CUSIP No. 55068A100 SCHEDULE 13G Page 6 of 7

     

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
       
      The Investment Vehicle has the right to receive and the power to direct the receipt of dividends from, and the proceeds from the sale of, the Common Stock.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      Not applicable.
       
    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
      Not applicable.
       
    Item 10. Certification.
       
      By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

      

     

     

    CUSIP No. 55068A100 SCHEDULE 13G Page 7 of 7

     

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date:  February 16, 2021

     

      D1 CAPITAL PARTNERS L.P.  
           
      By: /s/ Amanda Hector  
        Name:  Amanda Hector  
        Title:  General Counsel and Chief Compliance Officer  
           
      /s/ Daniel Sundheim  
      DANIEL SUNDHEIM  

     

     

     

      

     

    EXHIBIT A

    JOINT FILING AGREEMENT

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Date:  February 16, 2021

     

      D1 CAPITAL PARTNERS L.P.  
           
      By: /s/ Amanda Hector  
        Name:  Amanda Hector  
        Title:  General Counsel and Chief Compliance Officer  
           
      /s/ Daniel Sundheim  
      DANIEL SUNDHEIM   

     

     

      

    Get the next $LUXA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LUXA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LUXA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lux Health Tech Acquisition Corp. Announces Cancellation of Special Meeting of Stockholders and Liquidation

    Lux Health Tech Acquisition Corp. (the "Company") today announced that it has cancelled its special meeting of stockholders that was previously scheduled for 9:00 AM Pacific time on October 13, 2022, and that, because the Company will not consummate an initial business combination within the time period required by its Second Amended and Restated Certificate of Incorporation, the Company intends to dissolve and liquidate, effective as of the close of business on October 29, 2022, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximately $1

    10/7/22 4:15:00 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    Lux Health Tech Acquisition Corp. Signs Letter of Intent for a Business Combination

    Lux Health Tech Acquisition Corp. (the "Company") today announced that it has entered into a non-binding letter of intent ("LOI") for a business combination with a leading life sciences company addressing significant unmet needs in some of the most costly and debilitating segments of healthcare (the "Target"). The Target has an experienced executive and scientific leadership team that has built an extensive technology platform with multiple programs in development, and is backed by leading private and public market investors. The Company expects that it can offer the Target its resources, experience and network of relationships to support the Target's growth and access to public markets, m

    9/6/22 8:10:00 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    $LUXA
    SEC Filings

    View All

    SEC Form 15-12G filed by Lux Health Tech Acquisition Corp.

    15-12G - Lux Health Tech Acquisition Corp. (0001823767) (Filer)

    11/8/22 4:05:16 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    SEC Form 25-NSE filed by Lux Health Tech Acquisition Corp.

    25-NSE - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    10/28/22 4:24:39 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    Lux Health Tech Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Lux Health Tech Acquisition Corp. (0001823767) (Filer)

    10/7/22 4:29:45 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    $LUXA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Lux Health Tech Acquisition Corp. (Amendment)

    SC 13G/A - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    1/19/23 7:23:30 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Lux Health Tech Acquisition Corp. (Amendment)

    SC 13G/A - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    2/14/22 10:08:51 AM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G filed by Lux Health Tech Acquisition Corp.

    SC 13G - Lux Health Tech Acquisition Corp. (0001823767) (Subject)

    2/11/22 12:22:40 PM ET
    $LUXA
    Consumer Electronics/Appliances
    Industrials